M&A Deal Summary |
|
---|---|
Date | 2020-03-31 |
Target | Command Alkon |
Sector | Information Technology |
Buyer(s) |
Thoma Bravo
HeidelbergCement |
Sellers(s) |
Quilvest Capital Partners
Pegasus Capital Advisors |
Deal Type | Secondary Buyout |
Advisor(s) | Dechert (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1980 |
PE ASSETS | 127.0B USD |
Size | Mega |
Type | Sector Agnostic |
Thoma Bravo is a private equity firm that primarily invests in or acquires US-based middle-market businesses. While Thoma Bravo will consider a variety of transaction situations, including take-privates, buyouts, carve-outs, recapitalizations, and growth equity financings, the Firm has a special interest in tech consolidation opportunities. Target companies generally have a history of profitability with EBITDA of at least $20 million. The Firm's equity commitment size range is $100 to $750 million. Sectors of interest include enterprise and infrastructure software, education, distribution, financial services and consumer goods/services. The Firm will not invest in new inventions or technologies, developmental products or services, start-ups, biotech, motion pictures, distressed businesses, oil/gas, or real estate. Thoma Bravo was formerly known as Thoma Cressey Bravo and before that Golder Thoma & Co. The Firm was originally formed in 1980 and is based in Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 88 of 139 |
Sector (Information Technology) | 23 of 35 |
Type (Secondary Buyout) | 24 of 31 |
State (Alabama) | 1 of 1 |
Country (United States) | 80 of 120 |
Year (2020) | 1 of 11 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-03-02 |
Compuware
Detroit, Michigan, United States Compuware Corp. empowers the world’s largest companies to excel in the digital economy by taking full advantage of their mainframe investments. Compuware Corp. does this by delivering innovative software that enables IT, professionals, with mainstream skills to develop, deliver and support mainframe applications with ease and agility. Our modernized solutions uniquely automate mainframe work, integrate into a cross-platform DevOps toolchain and measure software delivery quality, velocity and efficiency. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-05-07 |
Apttus
San Mateo, California, United States Apttus is a global provider of the Intelligent Middle Office platform allowing enterprises to automate and optimize their most critical revenue and commercial relationship management processes. Apttus is powered by the Apttus Intelligent Cloud, a hybrid-cloud platform utilizing the most advanced technologies from Salesforce, Microsoft and IBM. Analysts rank Apttus as the global gold standard for Quote-to-Cash (QTC) and Contract Lifecycle Management (CLM) solutions. Apttus’ innovations include Max, the company’s Applied Artificial Intelligence that enables enterprises to achieve superior business outcomes. Apttus partners with a world-class ecosystem. Apttus was founded in 2006 and is based in San Mateo, California. |
Sell | - |
Category | Company |
---|---|
Founded | 1873 |
Sector | Building Materials |
Employees | 50,780 |
Revenue | 21.2B EUR (2023) |
HeidelbergCement is a German multinational building materials company headquartered in Heidelberg, Germany. HeidelbergCement a market leader in aggregates and a prominent player in the fields of cement, concrete and other downstream activities, making it one of the world’s largest manufacturers of building materials. HeidelbergCement was founded in 1873 and is based in Heidelberg, Germany.
DEAL STATS | # |
---|---|
Overall | 4 of 6 |
Sector (Information Technology) | 1 of 1 |
Type (Secondary Buyout) | 1 of 1 |
State (Alabama) | 1 of 1 |
Country (United States) | 1 of 2 |
Year (2020) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-01-02 |
Cementir Italia
Rome, Italy Cementir Italia SpA business includes 5 integrated cement plants and 2 cement grinding units with a total cement capacity of 5.5 million tonnes per year, as well as a network of terminals and concrete plants, all operating in Italy. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-05-10 |
Giatec
Ottawa, Ontario, Canada Giatec is a global company revolutionizing the construction industry by bringing smart testing technologies and real-time data collection to the forefront of every construction site. The company's suite of hardware and software products has leveraged advanced technologies, such as AI and the Internet of Things (IoT), including wireless concrete sensors, mobile apps, and advanced non-destructive testing technologies (NDT), to drive innovation throughout concrete's lifecycle and reduce concrete's carbon footprint. Giatec is based in Ottawa, Ontario. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1972 |
PE ASSETS | 6.0B USD |
Size | Mega |
Type | Sector Agnostic |
Quilvest Capital Partners is the private equity investment arm of asset management firm Quilvest. Quilvest Capital Partners invests in private equity and debt funds as well as makes direct investments. The direct investment group looks for opportunities in the US, Europe, and 'opportunistically' in Asia with a preference for buyout, growth capital, and venture transactions. Quilvest Capital Partners will consider both minority and majority positions. Quilvest Capital Partners was established in 1972 and is based Paris.
DEAL STATS | # |
---|---|
Overall | 60 of 68 |
Sector (Information Technology) | 4 of 4 |
Type (Secondary Buyout) | 22 of 25 |
State (Alabama) | 2 of 2 |
Country (United States) | 29 of 34 |
Year (2020) | 1 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-12-13 |
21st Century Oncology
Fort Myers, Florida, United States 21st Century Oncology is a provider of cancer care services across multiple modalities, the largest radiation oncology provider and one of the largest groups of urologists in the U.S. 21st Century Oncology was founded in 1983 and is based in Fort Myers, Florida. |
Sell | $1.1B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-06-15 |
Royalty Pharma
New York, New York, United States Royalty Pharma is a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals, and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly - directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 45 commercial products, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, and Vertex’s Kalydeco, Symdeko and Trikafta, and three development-stage product candidates. Royalty Pharma was formed in 1996 and is based in New York, New York. |
Sell | - |
Category | Private Equity Firm |
---|---|
Founded | 1996 |
PE ASSETS | 2.6B USD |
Size | Large |
Type | Sector Agnostic |
Pegasus Capital Advisors is a private equity firm focused on providing equity and junior capital to middle-market companies across a wide variety of industries. Pegasus looks to commit between $50 and $150 million per transaction. Sectors of interest include building materials, consumer products/services, energy, financial services/insurance, IT, marketing/communications, metals/minerals, and safety/security. Pegasus was formed in 1995 and is based in Stamford, Connecticut.
DEAL STATS | # |
---|---|
Overall | 14 of 16 |
Sector (Information Technology) | 1 of 1 |
Type (Secondary Buyout) | 3 of 3 |
State (Alabama) | 1 of 1 |
Country (United States) | 9 of 11 |
Year (2020) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-02-13 |
Six Senses Hotels Resorts Spas
Bangkok, Thailand Six Senses Resorts and Spas is an eco-conscious luxury resort and spa management company with branded properties in Asia, the Middle East, the Americas, and Europe. In all, Six Senses manages 10 resorts and 27 spas in 20 countries around the world under the Six Senses and Evason brands. |
Sell | $300M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-12-10 |
Healthe
Melbourne, Florida, United States Healthe is a technology provider in developing and deploying commercial and consumer solutions for UV air and surface sanitization and LED circadian lighting. These products inactivate viruses and bacteria in the air and on surfaces, improve air quality, regulate the body’s internal clock, boost performance and enhance sleep. Healthe is based in Melbourne, Florida. |
Sell | - |